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Abstract 
Review on ASCIZ/ATMIN, with data on 
DNA/RNA, on the protein encoded and where the 
gene is implicated. 
Keywords 
Apoptosis, dynein, DNA damage, transcription 
factor, lung 
Identity 
Other names: ASCIZ, ZNF822 
HGNC (Hugo): ATMIN 
Location: 16q23.2 
Local order: Gene orientation: centromere -5' 
ASCIZ/ATMIN 3'-telomere. ASCIZ/ATMIN is 
flanked towards the centromere by CENPN (in the 
same transcriptional orientiation) and towards the 
telomere by C16orf46 in opposite transcriptional 
orientation (NCBI Gene view, gene ID 23300, 
version 3-Jun-2014). 
Note: The gene was originally reported to encode 
an ATM-substrate Chk2-interacting Zinc-finger 
protein and referred to by the name ASCIZ in 
NCBI/Genbank, before the official gene name was 
changed to ATMIN by HGNC. 
 
DNA/RNA 
Description 
The human ASCIZ/ATMIN gene contains five 
exons over 11497 bases.  
The main transcript results from splicing of exon A, 
parts of exon C, and exons D and E and gives rise 
to the "full-length" protein containing 823 amino 
acids with four Zinc-fingers. Two alternative 
transcripts - comprising either exon B, part of exon 
C and exons D and E, or a longer exon C and exons 
D and E - give rise to a shorter 667-residue protein 
with only two Zinc-fingers.  
The mouse ASCIZ gene structure may be simpler 
with only four exons and single main mRNA 
encoding an 818-residue protein similar to the 
human 4-Zinc-finger product. 
Transcription 
In Northern and Western blot experiments, the two 
main isoforms of ASCIZ/ATMIN are expressed at 
relatively similar levels in a wide range of human 
tissues and all cancer-derived cell lines tested 
(McNees et al., 2005).  
Northern blots of various mouse tissues also 
indicate relatively similar expression levels in a 
wide range of organs (Jurado et al., 2010). 
 
 
Diagram 1. Genomic context of the human ASCIZ/ATMIN gene. Numbers indicate the nucleotide positions on chromosome 
16 (location 16q23.2). Arrows indicate the 5' to 3' orientation of each gene. Modified from NCBI Map Viewer. 
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Diagram 2. ASCIZ/ATMIN gene structure and main alternative splice isforms. ASCIZ/ATMIN contains 5 exons (A-E, center) 
that are spliced to two main open reading frames based on NCBI AceView. The lower splice isoform accounts for ~85% of 
transcripts collected in NCBI AceView and encodes an 823 amino acid residue protein with four N-terminal Zinc-fingers. The 
upper splice isoforms represent ~15% of transcripts and encodes a 667 residue protein with two N-terminal Zinc-fingers. Protein 
coding sequences are indicated by black boxes; non-coding exon sequences are indicated by open boxes; the grey part of exon 
C contains coding sequences when spliced into the 4-Zinc-finger transcript, but is out-of-frame as part of the 2-Zinc-finger 
transcript. The asterisk indicates an in-frame stop-codon in the 5'-UTR of the 2-Zinc-finger isoform. The scale bar on top 
represents 1 kb per notch. 
 
Pseudogene 
Two ASCIZ/ATMIN pseudogenes have been 
detected on chromosome 9 (LOC643342) and 
chromosome 12 (LOC100418940). 
Protein 
Note 
The human ASCIZ protein occurs in two isoforms. 
The more abundant long isoform contains 823 
amino acid residues with a mass of 88.3 kDa. The 
shorter isoform contains 667 residues with a mass 
of 72.3 kDa.  
The two isoforms are identical except that the first 
156 residues (including the first two Zinc fingers) 
of the longer form are missing in the shorter 
protein.  
Mouse ASCIZ contains 818 amino acids and is 
generally similar to the longer human isoform. 
Human and mouse ASCIZ exhibit atypical 
electrophoretic mobility on SDS-PAGE Western 
blots with an apparent mass of ~115 kDa rather 
than the predicted ~88 kDa (McNees et al., 2005). 
The aberrant mobility is unlikely to be caused by 
post-translational modifications, as similar mobility 
retardation is also observed with bacterially 
expressed recombinant fragments encompassing the 
SQ/TQ cluster. 
Description 
ASCIZ contains four (or two in the shorter isoform) 
C2H2 Zinc-fingers at the N-terminus, a so-called 
core domain, and a C-terminal transcription 
activation domain.  
Human ASCIZ contains 20 potential ATM/ATR 
kinase phosphorylation sites, most of which are 
clustered in an SQ/TQ cluster domain coinciding 
with the transcription activation domain (Heierhorst 
et al., 2011).  
11 of these sites are TQT motifs and represent 
binding sites for the DYNLL1 protein (Rapali et al., 
2011; Jurado et al., 2012a). 
Expression 
Based on Western blots, the ASCIZ protein is 
ubiquitously expressed at similar levels in all 
mouse tissues, with slightly higher levels in brain 
and testis (Jurado et al., 2010).  
Protein expression has not been systematically 
analysed in human tissues but is expected to be 
similar to mRNA expression profiles by Northern 
blots suggesting ubiquitous expression (McNees et 
al., 2005). 
 
 
Diagram 3. Topology of the ASCIZ protein. Only the long form is depicted. The shorter form is identical except for lack of the 
N-terminal 156 residues including the first two Zinc fingers (ZF). Lollipops indicate the 20 SQ/TQ motifs that are potential 
ATM/ATR kinase phosphorylation sites, including the 11 TQT motif DYNLL1-binding sites in the transcription activation domain. 
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Localisation 
The ASCIZ protein is predominantly, if not 
exclusively, located to the nucleus but not the 
nucleolus (McNees et al., 2005; Kanu and Behrens, 
2007).  
The protein forms discrete sub-nuclear foci after 
treatment with methylating and oxidating DNA 
base damaging agents (McNees et al., 2005; Rapali 
et al., 2011). 
Function 
ASCIZ was originally identified as an ATM/ATR-
substrate and Chk2-interacting protein involved in 
the DNA base damage response (McNees et al., 
2005), and later independently re-isolated as an 
ATM-interacting protein (Kanu and Behrens, 
2007). However, based on recent genetic analyses 
its main role seems to involve essential 
developmental functions such as a Zinc-finger 
transcription factor (Heierhorst et al., 2011). 
Knockout mice that completely lack Asciz/Atmin 
die late during gestation (Jurado et al., 2010; Kanu 
et al., 2010) and exhibit a range of severe 
organogenesis defects, including most strikingly a 
complete absence of lungs (Jurado et al., 2010). An 
N-ethyl-N-nitrosourea (ENU)-generated mouse 
mutant, gasping-6, that contains a missense 
mutations of a Zinc-chelating Cys residue in the 
third Zinc-finger domain of Asciz/Atmin also dies 
during late gestation with overall similar 
phenotypic defects to the Asciz/Atmin null mice, 
including absent or hypomorphic lungs 
(Goggolidou et al., 2014). Conditional Asciz/Atmin 
KO mice generated using B lympoid-specific Cd19-
Cre (Loizou et al., 2011) or Mb1-Cre (Jurado et al., 
2012b) have reduced peripheral B cell numbers due 
to increased apoptotic cell death during B cell 
development in the bone marrow. 
The most highly downregulated gene in Asciz-
deficient cells is the dynein light chain subunit 
Dynll1 (Jurado et al., 2012a). Strikingly, DYNLL1 
protein can in turn bind to about a dozen individual 
sites - mostly encompassing TQT motifs - in the 
ASCIZ transcription activation domain (Rapali et 
al., 2011; Jurado et al., 2012a) and thereby inhibit 
its transcriptional activity in a concentration-
dependent manner (Jurado et al., 2012a), which 
provides a feedback mechanism to maintain stable 
DYNLL1 protein levels. The ability of ASCIZ to 
regulate expression of and bind to the DYNLL1-
like dynein light chain (called Cutup) is conserved 
in Drosophila (Zaytseva et al., 2014). 
The importance of DYNLL1 as an ASCIZ target is 
highlighted by findings that B cell developmental 
defects in conditional Mb1-Cre Asciz KO mice can 
be rescued by ectopic expression of DYNLL1, or 
simultaneous KO of the pro-apoptotic protein Bim 
whose activity is inhibited by DYNLL1 (Jurado et 
al., 2012b). Likewise, in Drosophila, RNAi 
knockdown of ASCIZ or Cutup lead to similar 
developmental defects, which in case of dASCIZ 
RNAi can be rescued by Cutup overexpression 
(Zaytseva et al., 2014). 
The role of ASCIZ in DNA damage responses 
remains unclear. Loss of ASCIZ leads to increased 
cell death in response to methylating or oxidating 
DNA damage in human, mouse and chicken cells 
(McNees et al., 2005; Oka et al., 2008; Jurado et al., 
2010; Kanu et al., 2010), and increased basal IgV 
gene conversion rates in the chicken DT40 B cell 
line (Oka et al., 2008). ASCIZ focus formation in 
response to methylating agents depends on 
DYNLL1 (Jurado et al., 2012a), but it is not known 
whether this also involves its transcription factor 
function. The B cell developmental defect of 
conditional Asciz/Atmin KO mice could not be 
rescued by deletion of tp53 or complementation 
with a pre-arranged B cell receptor transgene 
(Jurado et al., 2012b), supporting a DNA damage-
independent mechanism as cause of the B cell 
deficiency. ASCIZ was earlier reported to be 
required for ATM protein stability (and thus termed 
ATMIN) (Kanu and Behrens, 2007), but this was 
shown to be incorrect in several subsequent studies 
(Jurado et al., 2010; Loizou et al., 2011; Zhang et 
al., 2012). ASCIZ was reported to regulate ATM 
activation by DNA damage-independent chromatin 
perturbations (Kanu and Behrens, 2007; Zhang et 
al., 2012) but this was not confirmed in another 
study (Jurado et al., 2010). 
Homology 
ASCIZ protein sequences are highly conserved 
amongst all vertebrates from fish to mammals 
(Kanu and Behrens, 2007; Jurado et al., 2012a). 
The ASCIZ protein is structurally and functionally 
conserved in Drosophila, where it also contains four 
N-terminal Zinc-fingers and a TQT-rich C-terminal 
transcription activation domain, condensed into 
only 388 amino acid residues (Zaytseva et al., 
2014). 
Mutations 
Note 
No specific disease-associated mutations of 
ASCIZ/ATMIN have so far been reported in 
humans, but an Asciz/Atmin mis-sense mutation 
has recently been identified as the cause of the 
gasping6 (Gpg6) ENU mouse mutant (Goggolidou 
et al., 2014). 
Germinal 
The gasping6 mouse mutation was isolated in an 
ENU mutagenesis screen (Ermakov et al., 2009). 
Asciz/Atmingpg6 mice exhibit exencephaly, edema 
and absent or small lungs (Ermakov et al., 2009)  
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and a modest kidney cell polarity defect 
(Goggolidou et al., 2014). Gpg6 mice contain a 
point mutation that converts the canonical fourth 
Zinc-chelating Cys residue in the third Zinc-finger 
domain to a non-chelating Ser residue (Goggolidou 
et al., 2014). Dynll1 was the most highly reduced 
mRNA amongst the analyzed transcripts in affected 
kidneys (Goggolidou et al., 2014). 
Implicated in 
B cell lymphoma 
Note 
Cd19-Cre conditional Asciz/Atmin deletion has 
been reported to cause B cell lymphoma in ~40% of 
mice (whose genetic background was not specified) 
before 1 year of age (Loizou et al., 2011), but 
deletion via Mb1-Cre (which is more efficient than 
Cd19-Cre during early B lympoid stages) in 
C57BL/6 mice did not lead to B cell lymphoma 
until at least 2 years of age (Jurado et al., 2012b). 
Irrespective of genetic background, no lymphomas 
were observed when Asciz/Atmin was deleted in 
earlier haematopoietic stem/progenitor cells via 
Mx1-Cre (Jurado et al., 2012b) or Vav2-Cre 
(Cremona and Behrens, 2014). 
Embryonic 
development/organogenesis 
Note 
Germline mutations of Asciz/Atmin in mice lead to 
late embryonic lethality (Jurado et al., 2010; Kanu 
et al., 2010; Goggolidou et al., 2014). Mice exhibit 
exencephaly, complete absence of lungs in the 
Asciz null mutation or a combination of absent and 
small lungs in the Asciz/Atmingpg6 point mutant, 
cardiac defects with oedema, and kidney defects. 
Haematopoiesis/B cell development 
Note 
Conditional Asciz/Atmin deletion during early B 
cell developmental stages in mice in the bone 
marrow leads to peripheral B cell deficiency, which 
is more severe with Mb1-Cre (Jurado et al., 2012b) 
than Cd19-Cre (Loizou et al., 2011). Pan-
haematopoietic inducible Asciz/Atmin deletion in 
adolescent mice via Mx1-Cre also leads to a 
statistically significant but modest and well 
tolerated anemia (Jurado et al., 2012b). 
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